Comparative molecular field analysis of fungal squalene epoxidase inhibitors

Journal of Medicinal Chemistry

Volumn 42, Issue 26, 1999, Pages 5348-5358

  Gokhale, Vijay M ^a   Kulkarni, Vithal M ^a  

^a UNIVERSITY OF MUMBAI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; BENZYLAMINE DERIVATIVE; OXYGENASE INHIBITOR; SQUALENE MONOOXYGENASE; TERBINAFINE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; DRUG CONFORMATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DYNAMICS; NONHUMAN; STRUCTURE ACTIVITY RELATION; TRICHOPHYTON MENTAGROPHYTES;

ELECTROSTATICS; ENZYME INHIBITORS; FUNGI; LEAST-SQUARES ANALYSIS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; OXYGENASES; SQUALENE MONOOXYGENASE;

EID: 0033619988     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9806852     Document Type: Article

References (43)

1. Ryder, N. S. Mode of Action of Allylamines. In Sterol Biosynthesis Inhibitors-Pharmaceutical and Agrochemical Aspects. Berg, D., Plempel, M., Eds.; VCH Publishers: Weinheim, 1988; p 151-167.
2. Stutz, A. Allylamine Derivatives - A New Class of Active Substances in Antifungal Chemotherapy. Angew. Chem., Int. Ed. Engl. 1987, 26, 320-328.
3. Ryder, N. S. Inhibition of Squalene Epoxidase and Sterol Side-Chain Methylation by Allylamines. Biochem. Soc. Trans. 1980, 18, 45-46.
4. Ryder, N. S.; Dupont, M. Inhibition of Squalene Epoxidase by Allylamine Antimycotic Compounds - A Comparative Study of Fungal and Mammalian Enzymes. Biochem. J. 1985, 230, 765-770.
5. Paltauf, F.; Daum, G.; Zuder, G.; Hogenauer, G.; Schulz, G.; Seidl, G. Squalene and Ergosterol Biosynthesis In Fungi Treated with Naftifine, A New Antimycotic Agent. Biochim. Biophys. Acta 1982, 712, 268-273.
6. Nussbaumer, P.; Petranyi, G.; Stutz, A. Synthesis and Structure-Activity Relationships of Benzo[b]thienylallylamine Antimycotics. J. Med. Chem. 1991, 34, 65-73.
7. Nussbaumer, P.; Dorfstatter, G.; Grassberger, M. A.; Leitner, I.; Meingasser, J. G.; Thirring, K.; Stutz, A. Synthesis and Structure-Activity Relationships of Phenyl-substituted Benzylamine Antimycotics: A Novel Benzylbenzylamine Antifungal Agent for Systemic Treatment. J. Med. Chem. 1993, 36, 2115-2120.
8. Nussbaumer, P.; Dorfstatter, G.; Leitner, I.; Mraz, K.; Vylpel, H.; Stutz, A. Synthesis and Structure-Activity Relationships of Naphthalene-Substituted Derivatives of the Allylamine Antimycotic Terbinafine. J. Med. Chem. 1993, 36, 2810-2816.
9. Nussbaumer, P.; Leitner, I.; Stutz, A. Synthesis of Structure-Activity Relationships of the Novel Homopropargylamine Antimycotics. J. Med. Chem. 1994, 37, 610-615.
10. Nussbaumer, P.; Leitner, I.; Mraz, K.; Stutz, A. Synthesis and Structure-Activity Relationships of Side-Chain Substituted Analogues of the Allylamine Antimycotic Terbinafine Lacking the Central Amino Function. J. Med. Chem. 1995, 38, 1831-1836.
11. Cramer, R. D.; Patterson, D. E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
12. Klebe, G.; Abraham, U. On the Prediction of Binding Properties of Drug Molecules by Comparative Molecular Field Analysis. J. Med. Chem. 1993, 36, 70-80.
13. Waller, C. L.; Marshall, G. R. Three-Dimensional Quantitative Structure-Activity Relationship of Angiotensin Converting Enzyme and Thermolysin Inhibitors. II. A Comparison of CoMFA Models Incorporating Molecular Orbital Fields and Desolvation Free Energies Based on Active-Analogue and Complementary-Receptor-Field Alignment Rules. J. Med. Chem. 1993, 36, 2390-2403.
14. Depriest, S. A.; Mayer, D.; Naylor, C. B.; Marshall, G. R. 3D-QSAR of Angiotensin-Converting Enzyme and Thermolysin inhibitors: A Comparison of CoMFA Models Based on Deduced and Experimentally Determined Active Site Geometries. J. Am. Chem. Soc. 1993, 115, 5372-5384.
15. Waller, C. L.; Oprea, T. I.; Gliotti, A.; Marshall, G. R. Three-Dimensional QSAR of Human Immunodeficiency Virus (I) Protease Inhibitors. 1. A CoMFA Study Employing Experimentally Determined Alignment Rules. J. Med. Chem. 1993, 36, 4152-4160.
16. Raghavan, K.; Buolawmini, J. K.; Fesen, M.; Pommier, Y.; Kohn, K. W.; Weinstein, J. N. Three-Dimensional Quantitative Structure Activity Relationship (QSAR) of HIV Integrase Inhibitors: A Comparative Molecular Field Analysis Study. J. Med. Chem. 1995, 38, 890-897.
17. Tong, W.; Collantes, E. R.; Chen, Y.; Welsh, W. J. A Comparative Molecular Field Analysis Study of N-Benzylpiperidines as Acetylcholinesterase Inhibitors. J. Med. Chem. 1996, 39, 380-387.
18. Cho, S. J.; Garsia, M. L. S.; Bier, J.; Tropsha, A. Structure-Based Alignment and Comparative Molecular Field Analysis of Acetylcholinesterase Inhibitors. J. Med. Chem. 1996, 39, 5064-5071.
19. Ortiz, A. R.; Pastor, M.; Palomer, A.; Cruciani, G.; Gago, F.; Wade, R. C. Reliability of Comparative Molecular Field Analysis Models: Effects of Data Scaling and Variable Selection Using a Set of Human Synovial Fluid Phospholipase A2 Inhibitors. J. Med. Chem. 1997, 40, 1136-1148.
20. Carrigan, S. W.; Fox, P. C.; Wall, M. E.; Wani, M. C.; Bowen, P. J. Comparative Molecular Field Analysis and Molecular Modeling Studies of 20-(S)-Camptothecin Analogues as Inhibitors of DNA topoisomerase I and Anticancer/antitumor Agents. J. Comput.-Aided Mol. Des. 1997, 11, 71-78.
21. Kulkarni, S. S.; Kulkarni, V. M. Three-Dimensional Quantitative Structure Activity Relationship of Interleukin-1β Converting Enzyme Inhibitors: A Comparative Molecular Field Analysis Study. J. Med. Chem. 1999, 42, 373-380.
22. Loghney, D. A.; Schwender, C. F. A Comparison of Progestin and Androgen Binding using the CoMFA technique. J. Comput.-Aided Mol. Des. 1992, 6, 569-581.
23. Allen, M. S.; LaLoggia, A. J.; Dorn, L. J.; Martin, M. J.; Constatino, G.; Hagen, T. J.; Koehler, K. F.; Skolnick, P.; Cook, J. M. Predictive Binding of β-Carboline Inverse Agonists and Antagonists via CoMFA/GOLPE Approach. J. Med. Chem. 1992, 35, 4001-4010.
24. Krystek, S. R.; Hunt, J. T.; Stein, P. D.; Stouch, T. R. Three-Dimensional Quantitative Structure Activity Relationship of Sulfonamide Endothelin Inhibitors. J. Med. Chem. 1995, 38, 659-668.
25. Sicsic, S.; Serraz, I.; Andrieux, J.; Bremont, B.; Allanmant, M. M.; Poncet, A.; Shen, S.; Langlois, M. Three-Dimensional Quantitative Structure-Activity Relaionship of Melatonin Receptor Ligands: A Comparative Molecular Field Analysis Study. J. Med. Chem. 1997, 40, 739-748.
26. Moro, S.; Rhee, A. M.; Sanders, L. H.; Jacobson, K. A. Flavonoid Derivatives as Adenosine Receptor Antagonists: A Comparison of the Hypothetical Receptor Binding Site Based on a Comparative Molecular Field Analysis Model. J. Med. Chem. 1998, 41, 46-52.
27. Corelli, F.; Manetti, F.; Tafi, A.; Campiani, G.; Nacci, V.; Botta, M. Diltiazem-like Calcium Entry Blockers. A Hypothesis of the Receptor-Binding Site Based on a Comparative Molecular Field Analysis Model. J. Med. Chem. 1997, 40, 125-131.
28. Bjokroth, J. P.; Pakkanen, T. A.; Lindroos, J.; Pohjala, E.; Hanhijarvi, H.; Lauren, L.; Hannuniemi, R.; Juhakoski, A.; Kippo, J. K.; Kleimola, T. Comparative Molecular Field Analysis of Clodronic Acid Esters. J. Med. Chem. 1991, 34, 2338-2343.
29. McFarland, J. W. Comparative Molecular Field Analysis of Anticoccidial Triazines. J. Med. Chem. 1992, 35, 2543-2550.
30. Horwitz, J. P.; Massova, I.; Wiese, T. E.; Wozniak, A. J.; Corbett, T. H.; Seabolt-Leopold, J. S.; Capps, D. B.; Leopold, W. R. Comparative Molecular Field Analysis of in Vitro Growth Inhibition of L1210 and HCT-8 Cells by Some Pyrazoloacridines. J. Med. Chem. 1993, 36, 3511-3516.
31. Gamper, A. M.; Winger, R. H.; Liedl, K. R.; Sotriffer, C. A.; Varga, J. M.; Kroemer, R. T.; Rode, B. M. Comparative Molecular Field Analysis of Haptens Docked to the Multispecific Antibody IgE (Lb4). J. Med. Chem. 1996, 39, 3882-3888.
32. Diana, G. D.; Kowalczyk, P.; Treasurywala, A. M.; Oglesby, R. C.; Pevear, D. C.; Dutko, F. J. CoMFA Analysis of the Interaction of Antipicornavirus Compounds in the Binding Pocket of Human Rhinovirus-14. J. Med. Chem. 1992, 35, 1002-1008.
33. Martinez, A.; Ochoa, C.; Rodriguez, J.; Rodriguez, M.; Castro, A.; Gonzalez, M.; Martinez, M. M. Comparative Molecular Field Analysis (CoMFA) on [6] + [6] Fused Pyrazines with Nematocide Properties. Quant. Struct. -Act. Relat. 1997, 16, 372-376.
34. Kroemer, R. T.; Koutsilieri, E.; Hecht, P.; Liedl, K. R.; Riederer, P.; Kornhuber, J. Quantitative Analysis of the Structural Requirements for Blockade of the N-Methyl D-aspartate Receptor at the Phencyclidine Binding Site. J. Med. Chem. 1998, 41, 393-400.
35. Hecht, P.; Vylpel, H.; Nussbaumer, P.; Berner, H. A Combined Use of Quantum Chemical Parameters, Hydrophobic and Geometrical Descriptors to Establish QSARs of Allylamine Antimycotics. Quant. Struct.-Act. Relat. 1992, 11, 339-347.
36. SYBYL 6.22 is available from Tripos Associates Inc., Hanley Road, St. Louis, MO 63144-2913.
37. Clark, M.; Cramer, R. D., III; Van Opdenbosh, N. Validation of the General-Purpose Tripos 5.2 force field. J. Comput. Chem. 1989, 10, 982-1012.
38. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. G.; Stewart, J. J. P. AM1: A New General Purpose Quantum Mechanical Molecular Model. J. Am. Chem. Soc. 1985, 107, 3902-3909.
39. Dewar, M. J. S.; Thiel, W. Ground State of Molecules: 38 The MNDO Method. Approximations and Parameters. J. Am. Chem. Soc. 1977, 99, 4899-4915.
40. MOPAC 6.00 is available from Quantum Chemical Program Exchange, Indiana University, no. 455.
41. Cerius2 3.5 is available from Molecular Simulation Inc., Scranton Road, San Diego, CA.
42. ClogP version 1.0.0; Biobyte Corp., 201 West 4th Street, Suite 204, Claremount, CA 91711.
43. Kaminski, J. J.; Doweyko, A. M. Antiulcer Agents 6. Analysis of the in vitro Biochemical and in vivo Gastric Antisecretory Activity of Substituted Imidazo[1,2-α]pyridines and Related Analogues Using Comparative Molecular Field Analysis and Hypothetical Active Site Lattice Methodologies. J. Med. Chem. 1997, 40, 427-436.